The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
NAFLD as a driver of chronic kidney disease
Abstract
Non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD) are worldwide public health problems, affecting up to 25-30% (NAFLD), and up to 10-15% (CKD) of the general population. Recently, it has also been established that there is a strong association between NAFLD and CKD, regardless of the presence of potential confounding diseases such as obesity, hypertension and type 2 diabetes. Since NAFLD and CKD are both common diseases that often occur alongside other metabolic conditions, such as type 2 diabetes or metabolic syndrome, elucidating the relative impact of NAFLD on the risk of incident CKD presents a substantial challenge for investigators working in this research field. A growing body of epidemiological evidence suggests that NAFLD is an independent risk factor for CKD and recent evidence also suggests that associated factors such as metabolic syndrome, dysbiosis, unhealthy diets, platelet activation and processes associated with ageing could also contribute mechanisms linking NAFLD and CKD. This narrative review provides an overview of the literature on: a) the evidence for an association and causal link between NAFLD and CKD and b) the underlying mechanisms by which NAFLD (and factors strongly linked with NAFLD) may increase the risk of developing CKD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Still, there is uncertainty as to whether there is a direct causal link between MASLD and CKD as both diseases share common risk factors. 227”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [227]
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00013 · Cited by 4,615
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
Hill, N. R., Fatoba, S., Oke, J. L., Hirst, J. A., O’Callaghan, C. A., Lasserson, D. S., & Hobbs, R. F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158765 · Cited by 4,320
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,162
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–449 of 449
Sun, Z., Yue, Y. G., & Li, P. (2024) · Research Square · doi:10.21203/rs.3.rs-5025893/v1
Rahmanian, M., Deravi, N., Poudineh, M., Poopak, A., Mirmohammadali, S. N., Fekrvand, S., Tadbir, K., Ebrahimian, S., Zargarzadeh, N., Pirzadeh, M., et al. (2024) · Egyptian Liver Journal · doi:10.1186/s43066-024-00393-w
Glendell, R. M., Puxty, K. A., Shaw, M., Sim, M. A. B., Traynor, J. P., Mark, P. B., & Andonovic, M. (2024) · Journal of the Intensive Care Society · doi:10.1177/17511437241308673
Khlynova, O. V., & Karpunina, N. S. (2025) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-228-8-123-130
High Prevalence of CKM Syndrome in the US and Chinese Population with MASLDPreprint
Wang, D., Yu, Q., Hu, S., Yao, N., Sun, Y., Liu, L., Wang, N., Wan, H., & Shen, J. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5145948
Ambulatory Acute Kidney Injury in Patients With Cirrhosis Is Common and Burdensome
Patidar, K. R., Hernáez, R., Liu, Y., Cholankeril, G. T., Kramer, J. R., Taylor, T., Jalal, P. K., Lee, T.-H., Flores, A. G., Cullaro, G., et al. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.03.015
Metabolic Dysfunction-Associated Steatohepatitis: An Important Juncture in Liver-Kidney Crosstalk
Sharma, S., Rajesh, C., & Dassi, M. (2025) · Kidney News · doi:10.62716/kn.000632025
Sharma, P., Sharma, K., Kumar, A., & Nandave, M. (2025) · Current Diabetes Reviews · doi:10.2174/0115733998380420250411073427
Vincenzo, A. D., Capone, F., & Rossato, M. (2025) · Internal and Emergency Medicine · doi:10.1007/s11739-025-04024-z
Non-alcoholic fatty liver disease and chronic kidney disease
Туркина, С. В., Андреевна, Т. И., & Титаренко, М. Н. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-230-10-49-61 · Cited by 1
Zhu, Y., Wang, Y., Zhang, S., Yang, J. C., Zhang, F., Liu, Y., Shang, J., Zhang, Y., Wang, J., & Liu, L. (2026) · Journal of Medical Internet Research · doi:10.2196/82529
Khajuria, A., & Singh, G. (2025) · Santosh University Journal of Health Sciences · doi:10.4103/sujhs.sujhs_10_25
Wang, Y., Liu, M., Li, W. L., Liu, Y., Tang, X., Sun, F., Zhu, H., & Tang, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1643842
Zeng, C., Lang, Q., Zhang, K., & Qian, X. (2025) · PLoS ONE · doi:10.1371/journal.pone.0334224
Karaaslan, H., Göçer, E. G., & Doğan, F. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01757-8
Beyond the epidemiological link: Targeting the gut-liver-kidney axis in hepatorenal disease
Chen, S., Chen, Y., & Chen, K. (2025) · Annals of Hepatology · doi:10.1016/j.aohep.2025.102163
Guo, W., Lu, J., Qin, P., Li, X., Zhu, W., Wu, J., Xu, N., & Zhang, Q. (2020) · Figshare · doi:10.6084/m9.figshare.13064341
Roderburg, C., Krieg, S., Krieg, A., Demir, M., Luedde, T., Kostev, K., & Loosen, S. H. (2023) · Figshare · doi:10.6084/m9.figshare.22641091
Kasem, H. E., AbdElAtty, E., Yahia, A. M. M., & Abdalla, E. (2024) · Figshare · doi:10.6084/m9.figshare.26640859
Zou, H., Xu, Y., Meng, X., Li, D., Chen, X., Du, T., Yang, Y., Chen, Y., 邵诗颖, Yuan, G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14843190
Deng, M., Wen, Y., Yan, J., Fan, Y., Wang, Z., Zhang, R., Ren, L., Ba, Y., Wang, H., Lu, Q., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24580347
Feng, Q., Manousou, P., Izzi‐Engbeaya, C. N., & Woodward, M. (2025) · medRxiv · doi:10.64898/2025.12.23.25342903
Zou, Y., Cao, Z., Chen, Y., Yuan, M., Zhang, Z., Gu, W., Wang, J., Zhao, S., & Hong, J. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s573217
Abdou, H. A., & Omar, S. A. (2026) · ASIDE Gastroenterology · doi:10.71079/aside.gi.031826446
Kim, A., Kang, D., Choi, S. C., Sinn, D. H., Jang, H. R., & Gwak, G. (2026) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2026.100827
Nguefang, G., Boateng, S., Issaka, Y., Eze, E., Al‐Ajlouni, Y. A., Ameyaw, P. A., Landa, E. L., Verma, A., Kaur, A., Mekontso, J. G. K., et al. (2026) · Medicine · doi:10.1097/md.0000000000048142
Cui, H., Xu, Y., Zhang, J., Cao, Q., Zhang, J., Cheng, X., Zhang, X., Guo, H., Wu, T., He, J., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113237
Jung, C., Lee, H. W., Lee, J. I., Lee, H. A., & Kim, S. W. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70730
Kang, S. W., Kim, S. K., Ban, J. Y., & Park, M. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27093920
Zhang, Y., Sun, Y., Liu, J., Dong, J., Cao, C., Qi, M., Li, S., Zhang, H., Gao, Z., & Song, H. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.115842
Wang, X., Yang, Y., Meng, Q., Zhang, X., & Wang, S.-Y. (2026) · Digital Health · doi:10.1177/20552076261467497
Li, Z., Yang, Q., Zang, L., Leng, H., Qin, P., Li, S., Tian, B., Deng, X., Sun, Y., & Xiao, X. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113411
He, X.-L., Yang, R.-X., & Fan, J.-G. (2026) · Hepatoma Research · doi:10.20517/2394-5079.2026.32
Singh, R., Gupta, G., Vikram, N. K., & Pandey, R. M. (2026) · Sleep and Vigilance · doi:10.1007/s41782-026-00365-7
Li, L., Chen, J., Hu, W., Wang, J., Wang, F. J., Dong, C., Wang, L., Chang, T., Guo, J., Cui, Y., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1863189
Iwaki, M., Fujii, H., Kamada, Y., Suzuki, Y., Sawada, K., Tatsuta, M., Maeshiro, T., Tobita, H., Tsutsumi, T., Akahane, T., et al. (2026) · Hepatology Research · doi:10.1111/hepr.70224
Younis, M. A., Hashim, M. S., Zaghloul, A., Mohammed, A. H., & Ahmed, N. M. (2026) · Egyptian Journal of Basic and Applied Sciences · doi:10.1080/2314808x.2026.2715797
Impact of Menopause and Menopausal Hormone Therapy on Liver–Kidney–Metabolic Health
Jamalinia, M., Lonardo, A., & Weiskirchen, R. (2026) · Advances in Therapy · doi:10.1007/s12325-026-03758-2
Qu, H., Zhou, L., 胡金华, Tang, D., & Lü, Y. (2026) · International Journal of Endocrinology · doi:10.1155/ije/8147661
Mahajan, N., Kaur, N., Sandhu, S. P. S., Patel, V., Boparai, H. K., Singh, K., & Singh, F. R. (2026) · Cureus · doi:10.7759/cureus.115501
Park, H. J., & Kim, S. W. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1923883
Wei, S., He, H., Xie, Y., Wang, Y., & Zhou, X. (2026) · Cytotechnology · doi:10.1007/s10616-026-01057-w
Crespo, J., Iruzubieta, P., de Vega, T., & Calleja, J. L. (2026) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2026.107536
Azizollahi, M., Ghasemi, M., Nasehi, Z., Amani, M., & Zadhoush, F. (2026) · BioMed Research International · doi:10.1155/bmri/9927792
Abdelaziz, H. R. E., Bader, A. F., Hassan, A. M., Mohamed, M. F., & Ali, A. E. W. F. (2026) · Al-Azhar Assiut Medical Journal · doi:10.4103/azmj.azmj_92_25
Boutari, C., Charalampidis, K., Sideras, L., Sinakos, E., & Goulis, I. (2026) · Life · doi:10.3390/life16101656
Innovative holistic treatment for CKM: what lies ahead?
Balfanz, P., & Marx, N. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.107222
Cheng, X., Li, Y., Zhu, M., 蔡亞潔, Wei, N., Liu, Y., & Liu, Y. (2026) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2026.10.002
Metadata
- Authors
- Byrne, C. D., & Targher, G.
- Affiliations
- University Hospital Southampton NHS Foundation Trust (GB)
- University of Verona (IT)
- Corresponding author
- Byrne, Christopher D.
- Targher, Giovanni
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 72
- Issue
- 4
- Pages
- 785-801
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W3006576880
- Cited by
- 449
- References
- 144
- Citations by year
- 2026: 45 · 2025: 72 · 2024: 76 · 2023: 85 · 2022: 79 · 2021: 57 · 2020: 34
- FWCI
- 9.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Funders
- NIHR Bristol Biomedical Research Centre (IS-BRC-20004)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- non-alcoholic fatty liver disease, chronic kidney disease, CKD risk factors, metabolic syndrome, dysbiosis, platelet activation, aging, type 2 diabetes, obesity, hypertension, unhealthy diet, pathophysiological mechanisms
- MeSH terms
- Adolescent, Adult, Aging, Child, Diabetes Mellitus, Type 2, Diet, Female, Humans, Male, Middle Aged, Obesity, Risk Factors, Platelet Activation, Comorbidity, Prevalence, Metabolic Syndrome, Renal Insufficiency, Chronic, Young Adult, Dysbiosis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
